Asthma Management System

Respiri (ASX:RSH) enters US distribution deal with mTelehealth

Markets Reporter jessica.defreitas@themarketherald.com.au 23 December 2021 14:54 (AEDT) Respiri (RSH) signs a five-year non-exclusive distribution and […]

Respiri (ASX:RSH) enters US distribution deal with mTelehealth Read More »

wheezo – Digital Wheeze Monitor – Owner’s Manual

[dflip id=”39283″][/dflip]

wheezo – Digital Wheeze Monitor – Owner’s Manual Read More »

wheezo – Digital Wheeze Monitor – Quick Start Guide

[dflip id=”39288″][/dflip]

wheezo – Digital Wheeze Monitor – Quick Start Guide Read More »

Respiri (ASX:RSH) receives FDA tick for Wheezo

Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing

Respiri (ASX:RSH) receives FDA tick for Wheezo Read More »

Post pagination

← Previous 1 2

Disclaimers

The reference ranges and insights presented in the SiPhox Health dashboard are meant to improve readability and provide context, however you should consult with your physician for a more formal interpretation of your results. No communication from SiPhox Health is meant to be or should be taken as medical advice. SiPhox Health is a wellness-only service and is not designed to diagnose or treat any disease. If you are concerned about any of the data in your dashboard please consult your physician immediately.

Google
#
Twitter
YouTube

Scroll to Top